 Angela Czaja
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pediatrics | 11 | 2026 | 1112 | 2.660 |
Why?
| | Fellowships and Scholarships | 11 | 2025 | 355 | 2.140 |
Why?
| | Intensive Care Units, Pediatric | 8 | 2020 | 284 | 1.990 |
Why?
| | Clinical Competence | 9 | 2026 | 1241 | 1.770 |
Why?
| | Critical Care | 8 | 2026 | 694 | 1.570 |
Why?
| | Education, Medical, Graduate | 8 | 2026 | 557 | 1.560 |
Why?
| | Critical Illness | 6 | 2021 | 889 | 1.530 |
Why?
| | Arrhythmias, Cardiac | 3 | 2020 | 360 | 1.480 |
Why?
| | Internship and Residency | 6 | 2026 | 1255 | 1.210 |
Why?
| | Off-Label Use | 3 | 2023 | 48 | 1.060 |
Why?
| | Patient Readmission | 4 | 2014 | 756 | 0.980 |
Why?
| | Medicine | 3 | 2023 | 125 | 0.970 |
Why?
| | Needs Assessment | 4 | 2026 | 401 | 0.880 |
Why?
| | Transportation of Patients | 1 | 2025 | 68 | 0.880 |
Why?
| | Simulation Training | 2 | 2025 | 134 | 0.830 |
Why?
| | Catheterization, Central Venous | 2 | 2022 | 122 | 0.800 |
Why?
| | Patient Transfer | 1 | 2025 | 206 | 0.750 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1347 | 0.740 |
Why?
| | Palliative Care | 2 | 2021 | 996 | 0.740 |
Why?
| | Central Venous Catheters | 1 | 2022 | 52 | 0.710 |
Why?
| | Child | 32 | 2023 | 22537 | 0.710 |
Why?
| | International Classification of Diseases | 2 | 2020 | 143 | 0.660 |
Why?
| | Quality Indicators, Health Care | 2 | 2014 | 335 | 0.660 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 2018 | 12 | 0.560 |
Why?
| | Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 26 | 0.550 |
Why?
| | Cannula | 1 | 2018 | 27 | 0.550 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2018 | 72 | 0.540 |
Why?
| | Child, Preschool | 17 | 2021 | 11774 | 0.510 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 112 | 0.500 |
Why?
| | Noninvasive Ventilation | 1 | 2017 | 62 | 0.500 |
Why?
| | Healthcare Disparities | 2 | 2014 | 725 | 0.490 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2018 | 182 | 0.480 |
Why?
| | Heart Arrest | 1 | 2020 | 407 | 0.460 |
Why?
| | Enteral Nutrition | 1 | 2017 | 216 | 0.450 |
Why?
| | Respiratory Insufficiency | 1 | 2018 | 326 | 0.430 |
Why?
| | Physicians | 1 | 2023 | 938 | 0.420 |
Why?
| | Humans | 46 | 2026 | 144261 | 0.420 |
Why?
| | Heart Diseases | 2 | 2018 | 349 | 0.410 |
Why?
| | Infant | 15 | 2020 | 10022 | 0.410 |
Why?
| | Retrospective Studies | 14 | 2022 | 17009 | 0.400 |
Why?
| | Databases, Factual | 5 | 2020 | 1484 | 0.400 |
Why?
| | United States | 16 | 2025 | 15876 | 0.370 |
Why?
| | Reproducibility of Results | 4 | 2025 | 3403 | 0.350 |
Why?
| | Pediatric Nursing | 1 | 2011 | 44 | 0.340 |
Why?
| | Antidepressive Agents | 1 | 2012 | 242 | 0.320 |
Why?
| | Curriculum | 4 | 2026 | 1057 | 0.310 |
Why?
| | Electronic Health Records | 1 | 2018 | 1169 | 0.310 |
Why?
| | Sepsis | 2 | 2022 | 640 | 0.300 |
Why?
| | Hospitals, Pediatric | 3 | 2021 | 555 | 0.300 |
Why?
| | Thoracic Surgery | 1 | 2011 | 144 | 0.290 |
Why?
| | Nursing Staff, Hospital | 1 | 2011 | 158 | 0.290 |
Why?
| | Dexmedetomidine | 1 | 2009 | 44 | 0.290 |
Why?
| | Female | 20 | 2026 | 77976 | 0.290 |
Why?
| | Hospital Mortality | 4 | 2021 | 1027 | 0.290 |
Why?
| | Male | 21 | 2026 | 72035 | 0.280 |
Why?
| | Infant, Newborn | 8 | 2023 | 6424 | 0.280 |
Why?
| | Length of Stay | 3 | 2021 | 1335 | 0.280 |
Why?
| | Adolescent | 16 | 2023 | 22281 | 0.280 |
Why?
| | Emergencies | 1 | 2009 | 175 | 0.270 |
Why?
| | Hypnotics and Sedatives | 1 | 2009 | 214 | 0.250 |
Why?
| | Cohort Studies | 6 | 2020 | 5935 | 0.250 |
Why?
| | Honduras | 1 | 2026 | 16 | 0.250 |
Why?
| | Neonatology | 1 | 2025 | 28 | 0.220 |
Why?
| | Sexism | 1 | 2025 | 70 | 0.220 |
Why?
| | Cross-Sectional Studies | 6 | 2025 | 5813 | 0.220 |
Why?
| | Cultural Competency | 1 | 2025 | 92 | 0.220 |
Why?
| | Age Factors | 3 | 2020 | 3313 | 0.210 |
Why?
| | United States Food and Drug Administration | 2 | 2017 | 203 | 0.210 |
Why?
| | Risk Factors | 7 | 2020 | 10699 | 0.200 |
Why?
| | Surveys and Questionnaires | 7 | 2026 | 6021 | 0.200 |
Why?
| | Logistic Models | 3 | 2020 | 2104 | 0.200 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2011 | 884 | 0.190 |
Why?
| | Emergency Medicine | 1 | 2025 | 261 | 0.190 |
Why?
| | Faculty | 1 | 2023 | 149 | 0.180 |
Why?
| | Intubation, Intratracheal | 2 | 2018 | 320 | 0.180 |
Why?
| | Delphi Technique | 1 | 2023 | 329 | 0.170 |
Why?
| | Prescription Drugs | 1 | 2023 | 110 | 0.170 |
Why?
| | Consensus | 1 | 2023 | 488 | 0.170 |
Why?
| | Central Nervous System Stimulants | 1 | 2023 | 182 | 0.170 |
Why?
| | Wounds and Injuries | 1 | 2009 | 952 | 0.170 |
Why?
| | Ultrasonography, Interventional | 1 | 2022 | 160 | 0.170 |
Why?
| | Femoral Vein | 1 | 2020 | 38 | 0.160 |
Why?
| | Citalopram | 1 | 2020 | 32 | 0.160 |
Why?
| | Shock, Septic | 1 | 2022 | 215 | 0.150 |
Why?
| | Washington | 2 | 2011 | 146 | 0.150 |
Why?
| | Risk Assessment | 3 | 2017 | 3637 | 0.150 |
Why?
| | Health Status Indicators | 2 | 2011 | 165 | 0.150 |
Why?
| | Young Adult | 6 | 2020 | 13990 | 0.150 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 729 | 0.150 |
Why?
| | Muscular Dystrophy, Duchenne | 1 | 2020 | 91 | 0.140 |
Why?
| | Certification | 3 | 2025 | 119 | 0.140 |
Why?
| | Coronary Care Units | 1 | 2018 | 26 | 0.140 |
Why?
| | Adult | 9 | 2025 | 40262 | 0.130 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2018 | 81 | 0.130 |
Why?
| | Family Practice | 1 | 2021 | 403 | 0.130 |
Why?
| | Proportional Hazards Models | 2 | 2013 | 1322 | 0.130 |
Why?
| | Odds Ratio | 1 | 2020 | 1072 | 0.130 |
Why?
| | Faculty, Medical | 1 | 2020 | 301 | 0.120 |
Why?
| | Administration, Inhalation | 1 | 2018 | 574 | 0.120 |
Why?
| | Delirium | 1 | 2018 | 104 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2020 | 390 | 0.120 |
Why?
| | Pharmacoepidemiology | 1 | 2016 | 22 | 0.120 |
Why?
| | Epidemiologic Research Design | 1 | 2016 | 27 | 0.120 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2018 | 257 | 0.120 |
Why?
| | Hospitalization | 2 | 2020 | 2424 | 0.110 |
Why?
| | Time Factors | 3 | 2025 | 7155 | 0.110 |
Why?
| | Comorbidity | 2 | 2011 | 1646 | 0.110 |
Why?
| | Intensive Care Units | 1 | 2021 | 916 | 0.110 |
Why?
| | Referral and Consultation | 1 | 2021 | 847 | 0.110 |
Why?
| | Health Policy | 1 | 2017 | 398 | 0.100 |
Why?
| | Pharmaceutical Preparations | 1 | 2015 | 169 | 0.100 |
Why?
| | Insurance Claim Review | 1 | 2013 | 82 | 0.100 |
Why?
| | Case-Control Studies | 1 | 2020 | 3592 | 0.090 |
Why?
| | Algorithms | 1 | 2020 | 1834 | 0.090 |
Why?
| | Patient Discharge | 2 | 2022 | 977 | 0.090 |
Why?
| | Drug Approval | 1 | 2012 | 89 | 0.090 |
Why?
| | Managed Care Programs | 1 | 2012 | 136 | 0.090 |
Why?
| | Nursing Methodology Research | 1 | 2011 | 47 | 0.090 |
Why?
| | Hospital Units | 1 | 2011 | 32 | 0.090 |
Why?
| | Patient Admission | 1 | 2013 | 218 | 0.080 |
Why?
| | Multivariate Analysis | 2 | 2018 | 1533 | 0.080 |
Why?
| | Cardiac Output | 1 | 2011 | 179 | 0.080 |
Why?
| | Risk Adjustment | 1 | 2011 | 85 | 0.080 |
Why?
| | Risk | 1 | 2013 | 909 | 0.080 |
Why?
| | Incidence | 2 | 2018 | 2870 | 0.080 |
Why?
| | Ventilator Weaning | 1 | 2010 | 39 | 0.080 |
Why?
| | Biomedical Research | 1 | 2017 | 709 | 0.080 |
Why?
| | Anesthetics, Intravenous | 1 | 2010 | 69 | 0.080 |
Why?
| | Propofol | 1 | 2010 | 85 | 0.080 |
Why?
| | Colorado | 2 | 2017 | 4562 | 0.080 |
Why?
| | Device Removal | 1 | 2010 | 142 | 0.070 |
Why?
| | Models, Statistical | 1 | 2013 | 677 | 0.070 |
Why?
| | Aged | 3 | 2021 | 25850 | 0.070 |
Why?
| | Prognosis | 3 | 2018 | 4278 | 0.070 |
Why?
| | Postoperative Care | 1 | 2010 | 288 | 0.070 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 557 | 0.070 |
Why?
| | Cardiomyopathies | 1 | 2011 | 337 | 0.060 |
Why?
| | Chronic Disease | 1 | 2013 | 1812 | 0.060 |
Why?
| | Cause of Death | 1 | 2009 | 464 | 0.060 |
Why?
| | Ibuprofen | 1 | 2007 | 84 | 0.060 |
Why?
| | Follow-Up Studies | 2 | 2013 | 5389 | 0.060 |
Why?
| | Treatment Outcome | 2 | 2013 | 11643 | 0.060 |
Why?
| | Prospective Studies | 4 | 2022 | 7970 | 0.060 |
Why?
| | Efficiency | 1 | 2025 | 103 | 0.050 |
Why?
| | Heart Transplantation | 1 | 2011 | 736 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2012 | 2926 | 0.050 |
Why?
| | Burnout, Professional | 1 | 2011 | 484 | 0.050 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 338 | 0.050 |
Why?
| | Anxiety | 1 | 2011 | 1104 | 0.050 |
Why?
| | Pandemics | 2 | 2023 | 1682 | 0.050 |
Why?
| | Suicide, Attempted | 1 | 2007 | 404 | 0.050 |
Why?
| | Psychotropic Drugs | 1 | 2023 | 74 | 0.050 |
Why?
| | Heart Defects, Congenital | 1 | 2010 | 913 | 0.050 |
Why?
| | Extracorporeal Membrane Oxygenation | 1 | 2007 | 382 | 0.050 |
Why?
| | Competency-Based Education | 1 | 2022 | 79 | 0.040 |
Why?
| | Middle Aged | 3 | 2021 | 35762 | 0.040 |
Why?
| | Obesity | 1 | 2015 | 3057 | 0.040 |
Why?
| | Depression | 1 | 2011 | 1533 | 0.040 |
Why?
| | Health Resources | 1 | 2022 | 129 | 0.040 |
Why?
| | Aftercare | 1 | 2022 | 220 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2096 | 0.040 |
Why?
| | Hypertension, Pulmonary | 1 | 2011 | 1980 | 0.040 |
Why?
| | Survivors | 1 | 2022 | 516 | 0.030 |
Why?
| | Teaching | 1 | 2020 | 235 | 0.030 |
Why?
| | Aged, 80 and over | 1 | 2009 | 8243 | 0.030 |
Why?
| | Echocardiography | 1 | 2020 | 647 | 0.030 |
Why?
| | Ultrasonography | 1 | 2020 | 768 | 0.030 |
Why?
| | Stroke Volume | 1 | 2020 | 648 | 0.030 |
Why?
| | International Agencies | 1 | 2016 | 30 | 0.030 |
Why?
| | Sample Size | 1 | 2016 | 123 | 0.030 |
Why?
| | Glucocorticoids | 1 | 2020 | 533 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 850 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2015 | 32 | 0.030 |
Why?
| | Qualitative Research | 1 | 2022 | 1659 | 0.030 |
Why?
| | Drug Prescriptions | 1 | 2015 | 280 | 0.020 |
Why?
| | Information Dissemination | 1 | 2015 | 220 | 0.020 |
Why?
| | Decision Support Systems, Clinical | 1 | 2015 | 265 | 0.020 |
Why?
| | Body Weight | 1 | 2015 | 976 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2011 | 289 | 0.020 |
Why?
| | Regression Analysis | 1 | 2011 | 998 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2010 | 2026 | 0.010 |
Why?
| | Pilot Projects | 1 | 2011 | 1867 | 0.010 |
Why?
|
|
Czaja's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|